Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

rare and orphan diseases

- PMLiVE

Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development

The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients

- PMLiVE

Eli Lilly to expand long-standing Purdue University partnership with $250m investment

The alliance will aim to bring medicines to patients faster using advanced technologies

- PMLiVE

AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

The funds will go towards a new global research and development centre in Beijing’s BioPark

- PMLiVE

Chiesi Group invests €400m to establish biotech centre of excellence in Italy

The facility is dedicated to developing and producing monoclonal antibodies, enzymes and other proteins

- PMLiVE

Eli Lilly announces new $4.5bn US site for manufacturing and drug development

The Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers

- PMLiVE

Answering some of Pharma’s big questions to drive brand strategies

By James Aird and Zoë van Helmond

Amiculum

- PMLiVE

FDA establishes rare disease innovation hub to accelerate treatment development

More than 30 million people in the US are currently affected by a rare disease

- PMLiVE

Experts issue call for new ‘toolbox’ to simplify early-phase clinical trial regulation in UK

The article outlines several recommendations to help improve early-phase clinical trials

- PMLiVE

Sanofi, Formation Bio and OpenAI announce AI collaboration to accelerate drug development

The companies will combine data, software and tuned models to bring new medicines to patients more efficiently

- PMLiVE

AI drug discovery biotech Xaira Therapeutics launches with over $1bn in committed funding

The company combines machine learning, data generation and therapeutic product development

- PMLiVE

Early strategic planning: how to get ahead of the curve

By James Aird and Sarah Theobald

Amiculum

- PMLiVE

Date set for EU antitrust regulators to decide on Pfizer’s $43bn Seagen acquisition

The proposed transaction would mark a significant boost to the US pharma’s oncology pipeline

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links